These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 819713)

  • 1. A nonhuman primate vascular shunt model for thrombus generation.
    Mason RG; Wolf RH; Zucker WH; Shinoda BA
    Lab Invest; 1976 Jun; 34(6):558-64. PubMed ID: 819713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antithrombotic agents evaluated in a nonhuman primate vascular shunt model.
    Mason RG; Wolf RH; Zucker WH; Shinoda BA; Mohammad SF
    Am J Pathol; 1976 Jun; 83(3):557-68. PubMed ID: 820202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inhibition of acute platelet-dependent thrombosis in a baboon model by Bay U3405, a thromboxane A2-receptor antagonist.
    Kotzé HF; Lamprecht S; Badenhorst PN; van Wyk V; Roodt JP; Alexander K
    Thromb Haemost; 1993 Oct; 70(4):672-5. PubMed ID: 8115994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thrombosis on prosthetic surfaces. Evolution and blood coagulation studies in a nonhuman primate model.
    Rodman NF; Wolf RH; Mason RG
    Am J Pathol; 1974 May; 75(2):229-42. PubMed ID: 4207269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic modification of acute vascular graft thrombosis.
    Hanson SR; Reidy MA; Hattori A; Harker LA
    Scan Electron Microsc; 1982; (Pt 2):773-9. PubMed ID: 6762650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention.
    Harker LA; Hanson SR
    J Clin Invest; 1979 Aug; 64(2):559-60. PubMed ID: 110835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A canine ex vivo series shunt for evaluating thrombus deposition on polymer surfaces.
    Lelah MD; Lambrecht LK; Cooper SL
    J Biomed Mater Res; 1984; 18(5):475-96. PubMed ID: 6736079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of silastic tubing wall thickness on ex vivo thrombus formation in a series shunt.
    Lelah MD; Grasel TG; Pierce JA; Lambrecht LK; Cooper SL
    Trans Am Soc Artif Intern Organs; 1984; 30():411-6. PubMed ID: 6533917
    [No Abstract]   [Full Text] [Related]  

  • 10. DX-9065a, an orally active, specific inhibitor of factor Xa, inhibits thrombosis without affecting bleeding time in rats.
    Hara T; Yokoyama A; Tanabe K; Ishihara H; Iwamoto M
    Thromb Haemost; 1995 Aug; 74(2):635-9. PubMed ID: 8584999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
    Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
    Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallel flow arteriovenous shunt for the ex vivo evaluation of heparinized materials.
    Ip WF; Zingg W; Sefton MV
    J Biomed Mater Res; 1985 Feb; 19(2):161-78. PubMed ID: 4077878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost.
    Peters RF; Lees CM; Mitchell KA; Tweed MF; Talbot MD; Wallis RB
    Thromb Haemost; 1991 Mar; 65(3):268-74. PubMed ID: 1710836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterio-venous shunt with percutaneous leads in calves for long-term in vivo testing of blood-contact materials.
    Grosse-Siestrup C; Krautzberger W; Bücherl ES
    J Biomed Mater Res; 1979 Jan; 13(1):15-22. PubMed ID: 155070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disseminated intravascular coagulation following peritoneo-venous (LeVeen) shunt.
    Gibson PR; Dudley FJ; Jakobovits AW; Salem HH; McInnes IE
    Aust N Z J Med; 1981 Feb; 11(1):8-12. PubMed ID: 6941784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation.
    Busch GJ; Kobayashi K; Hollenberg NK; Birtch AG; Colman RW
    Am J Pathol; 1975 Jul; 80(1):1-20. PubMed ID: 1098475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of thrombus formation on surfaces.
    Schultz JS; Lindenauer SM; Penner JA; Barenberg S
    Trans Am Soc Artif Intern Organs; 1980; 26():279-83. PubMed ID: 7245497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.